ArticleFrontiers in pharmacology2025

Atorvastatin as an immunomodulatory adjunct in ulcerative colitis, beyond lipid lowering to inflammation control: a randomized controlled pilot study.

Mohannad O Khrieba et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.